. Author manuscript; available in PMC: 2009 Oct 5.

Published in final edited form as: Bone Marrow Transplant. 2008 Oct 13;43(5):417–422. doi: 10.1038/bmt.2008.334

Table 1.

Demographic and clinical characteristics at diagnosis and at the time of the initial auto-SCT

Variable	Number (range or percent) or median (range) (n = 41)
Gender	32 male, 9 female
Age at diagnosis	50 years (25–69)
Ig subtype
IgG	25 (61%)
IgA	5 (12%)
κ-Light chain	6 (15%)
λ-Light chain	4 (10%)
Non-secretory	1 (2%)
Durie Salmon stage at diagnosis
I	8 (20%)
II	10 (24%)
III	14 (34%)
Missing	9 (22%)
Age at initial auto-SCT	51 years (25–70)
Conditioning
Melphalan 200 mg/m²	32 (78%)
Reduced dose melphalan	4 (10%)
BU/CY	4 (10%)
CY/TBI	1 (2%)
Response
CR	9 (22%)
VGPR	3 (7%)
PR	21 (51%)
SD	6 (15%)
PD	2 (5%)
TTP after initial auto-SCT	21 months (3–73)

Abbreviations: PD = progressive disease; PR = partial response; SD = stable disease; TTP = time to progression; VGPR = very good partial response.